Illumina Dropped List Prices, Cut Discounts for Infinium Kits After Affy Slashed 500K Price | GenomeWeb
NEW YORK (GenomeWeb News) — Illumina CEO Jay Flatley said the company in September dropped the list prices and reduced the discounts for its Infinium whole-genome genotyping kits a few weeks after rival Affymetrix cut the price of its 500K array kit.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.